18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer Patients
NCT07485881 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 59
Last updated 2026-03-20
Summary
To compare the diagnostic performance of 18-F PSMA PET/CT and CT alone in initial staging, assessment of therapy response, as well as evaluation of biochemical recurrence of prostatic cancer patients
The main question it aims to answer is:
Does 18-F PSMA PET/CT have a superior role over CT in evaluation of prostatic cancer patients?
Conditions
- Prostate Cancer
- Prostate Cancer Metastatic
- Prostate Cancer Recurrent
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-05-01
- Primary Completion
- 2028-05-31
- Completion
- 2028-06-30
More Related Trials
-
The Application Value of Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA Grey Area Prostate Cancer
NCT05958004 ·Status: COMPLETED
-
18F-PSMA-1007 PET Imaging to Detect Primary Prostate Cancer
NCT04487847 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer
NCT05815316 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Application Value of 18F-prostate-specific Membrane Antigen PET/CT in Prostate Cancer
NCT04521894 ·Status: UNKNOWN
-
18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients
NCT05141760 ·Status: COMPLETED ·Phase: PHASE2
-
PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma
NCT01304485 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate Cancer
NCT03451812 ·Status: UNKNOWN
-
18F-FACBC PET/CT and the PSA Kinetics for PCa Patients With Biochemical Recurrence.
NCT05048537 ·Status: UNKNOWN ·Phase: NA
-
Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR
NCT03149861 ·Status: COMPLETED ·Phase: NA
-
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
NCT04742361 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer
NCT06612047 ·Status: RECRUITING
-
rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance
NCT05852041 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer
NCT06122584 ·Status: RECRUITING ·Phase: PHASE3
-
Prostate Cancer 18F-PSMA-1007 PET/CT Access Trial
NCT06489496 ·Status: NOT_YET_RECRUITING
-
Detection Rate of Prostate Cancer in Men Undergoing MRI
NCT04398173 ·Status: COMPLETED
-
F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence
NCT04102553 ·Status: COMPLETED ·Phase: PHASE3
-
18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028
NCT05520255 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan
NCT01777061 ·Status: NO_LONGER_AVAILABLE
-
68Ga-PSMA PET in the Prostate Cancer
NCT04967001 ·Status: RECRUITING ·Phase: NA
-
Study of Diagnostic Performance of [18F]CTT1057 in BCR
NCT04838613 ·Status: COMPLETED ·Phase: PHASE3
-
An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer
NCT04978675 ·Status: COMPLETED ·Phase: PHASE1
-
Pre-operative PET-MR of High Risk Prostate Cancer Patients for Assessment of Cancer Aggressiveness and Lymph Node Status
NCT02076503 ·Status: COMPLETED ·Phase: NA
-
Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer.
NCT06305390 ·Status: RECRUITING ·Phase: PHASE2
-
Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer
NCT03581500 ·Status: WITHDRAWN ·Phase: PHASE2
-
Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and Metastasis
NCT06462495 ·Status: RECRUITING ·Phase: EARLY_PHASE1